Pharmaceutical Executive April 26, 2024
Mike Hollan

PanOmiQ is referred to as the fasted technology of its kind by the company.

Human genome sequencing is about to get faster.

Genomic research and technology company BioAro announced that it is launching new software that is capable of real-time genomic analysis.1 PanOmiQ is billed as the fastest technology of its kind, and it will launch on May 9, 2024, at the Precision Medicine Expo in Dubai.

The technology is part of the company’s precision health inititative.

In a press release, BioAro founder and CEO Dr. Anmol S. Kapoor said, “Our team at BioAro are committed to pushing the boundaries of genomic research and technology through real-time genomic testing and analysis to provide enhanced quality of life and Healthspan. With...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma / Biotech, Precision Medicine
Putting Patients First by Extending the Reach of World-Class Care
Healthcare's most promising tech
AI In Healthcare: A New Era Of Personalized Patient Care
23andMe reports sales decline a day after announcing plans to cut 40% of workforce
Patient-derived organoids: Transforming cancer research and personalized medicine

Share This Article